Kenalog is a brand name for triamcinolone acetonide, a corticosteroid medication used to treat a variety of inflammatory and allergic conditions. It is available in several formulations, including injectable suspensions, topical creams and ointments, and nasal sprays [1].
What conditions does Kenalog treat?
Kenalog injections are commonly used for musculoskeletal conditions such as joint inflammation, bursitis, and tendinitis. It is also used to treat allergic reactions, skin conditions like eczema and psoriasis, and certain eye conditions [1].
How does Kenalog work?
As a corticosteroid, triamcinolone acetonide works by reducing inflammation. It suppresses the body's immune response, thereby alleviating symptoms associated with inflammatory and allergic conditions [1].
What are the different forms of Kenalog?
Kenalog comes in multiple forms to suit different treatment needs. These include:
* Injectable suspension: For intra-articular (joint), intralesional (into a lesion), or intramuscular injections.
* Topical preparations: Creams and ointments applied directly to the skin for dermatological issues.
* Nasal spray: Used for allergic rhinitis [1].
What are the potential side effects of Kenalog?
Side effects can vary depending on the route of administration. For injections, potential side effects include pain or swelling at the injection site, and systemic effects if absorbed into the bloodstream. Topical use can lead to skin thinning, acne, or changes in pigmentation. Long-term or high-dose use of corticosteroids can have more serious side effects, including effects on bone density, blood sugar levels, and the immune system [1].
When does the Kenalog patent expire?
Drug patent information can be complex and varies for different formulations and indications. For specific details on Kenalog's patent expiry, DrugPatentWatch.com provides a resource that tracks such information [2].
Who manufactures Kenalog?
Kenalog is manufactured by Bristol Myers Squibb [1].